6.85 USD
↘ 0.83 (10.81%)AT CLOSE (11:59 AM EDT)
Artiva Biotherapeutics, Inc. Common Stock
ARTVNASDAQ • USD
7.09
↗ 0.24 (3.47%)
POST MARKET (AS OF 07:44 PM EDT)
Post Market
AS OF 07:44 PM EDT
7.09
↗ 0.24 (3.47%)
Market: CLOSED
Open?$7.63
High?$7.80
Low?$6.79
Prev. Close?$7.68
Volume?361.1K
Avg. Volume?560.6K
VWAP?$7.05
Rel. Volume?0.64x
Bid / Ask
Bid?$6.87 × 800
Ask?$7.31 × 100
Spread?$0.44
Midpoint?$7.09
Valuation & Ratios
Market Cap?332.8M
Shares Out?24.7M
Float?5.7M
Float %?23.2%
P/E Ratio?N/A
P/B Ratio?3.79
EPS?-$1.79
Dividend?0.00%
Ex-Dividend?N/A
ARTV is currently priced at $6.85. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, ARTV trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
Themes
Employees
106
Market Cap
332.8M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2024-07-19
Address
5505 MOREHOUSE DRIVE
SAN DIEGO, CA 92121
Phone: (858) 267-4467
SAN DIEGO, CA 92121
Phone: (858) 267-4467
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?95
Momentum?23
Short Sent.?43
Piotroski F-Score?0/9Weak
Altman Z-Score?4.36Safe
Confidence?41%Low
Short InterestElevated
Short % of Float?8.45%Elevated
Short Interest?480.6K
Days to Cover?1.0
Free Float5.7M
Avg Daily Volume777.8K
Settlement Date2026-05-15
Financial Health
Current Ratio?8.16Strong
Quick Ratio?8.16Strong
Cash Ratio?1.93Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?3.79FAIR▾
Peers100
S&P46
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-3.5CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-99.1%WEAK▾
S&P3
ROA?-82.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-80178000
Enterprise Value?$311.9M
Fundamentals ratios updated end of day